hydrolyzed sodium chondroitin sulfate은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

hydrolyzed sodium chondroitin sulfate은 임신 중 안전한가요?

No harmonised CLP reproductive classifications (ECHA Annex VI) nor SCCS/CIR findings indicating reproductive hazard for chondroitin derivatives; literature on chondroitin (oral or topical) does not report teratogenicity or human reproductive effects. The ingredient is a large hydrophilic glycosaminoglycan derivative with low systemic bioavailability from topical use, so reproductive hazard is not indicated (sources: ECHA Annex VI absence, CIR none, PubMed reviews of chondroitin safety, CosIng listing).

hydrolyzed sodium chondroitin sulfate은 모유 수유 중 안전한가요?

No evidence of reproductive or lactation-specific toxicity; molecule size and hydrophilicity make significant systemic absorption and transfer into breast milk unlikely. No harmonised classifications or CIR/SCCS opinions raising concern (sources: ECHA Annex VI absence, PubMed, CosIng, EWG).

hydrolyzed sodium chondroitin sulfate은 아기 피부에 안전한가요?

Hazard and mechanism: no infant-specific reproductive/toxicologic evidence. Exposure: increased potential for percutaneous uptake in infants relative to adults is possible for substances with measurable dermal absorption; chondroitin derivatives are large, hydrophilic and expected to have negligible adult absorption, but because infant barrier is immature a conservative exposure score +1 is applied (adult e=0 → infant e=1). No data indicate infant-specific harms (sources: general dermal absorption principles, CosIng, PubMed).

VeriMom은 hydrolyzed sodium chondroitin sulfate을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 hydrolyzed sodium chondroitin sulfate을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 hydrolyzed sodium chondroitin sulfate 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.